BIRC5 and prostate cancer: Although previous studies have suggested that YM155 specifically blocks survivin expression in prostate cancer cells and non-small cell lung cancer (NSCLC) cells without affecting other proteins [9], [16], our data from pancreatic and gastric cancer cells except MKN45 cells suggest otherwise.